These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 34390780)

  • 1. Activation of PPARα-catalase pathway reverses alcoholic liver injury via upregulating NAD synthesis and accelerating alcohol clearance.
    Yue R; Chen GY; Xie G; Hao L; Guo W; Sun X; Jia W; Zhang Q; Zhou Z; Zhong W
    Free Radic Biol Med; 2021 Oct; 174():249-263. PubMed ID: 34390780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PPARα agonist WY-14,643 enhances ethanol metabolism in mice: Role of catalase.
    Chen X; Xu Y; Denning KL; Grigore A; Lu Y
    Free Radic Biol Med; 2021 Jun; 169():283-293. PubMed ID: 33892114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Under peroxisome proliferation acyl-CoA oxidase coordinates with catalase to enhance ethanol metabolism.
    Chen X; Denning KL; Mazur A; Lawrence LM; Wang X; Lu Y
    Free Radic Biol Med; 2023 Nov; 208():221-228. PubMed ID: 37567517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between fatty acid oxidation and ethanol metabolism in liver.
    Lu Y; George J
    Am J Physiol Gastrointest Liver Physiol; 2024 May; 326(5):G483-G494. PubMed ID: 38573193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apigenin protects against alcohol-induced liver injury in mice by regulating hepatic CYP2E1-mediated oxidative stress and PPARα-mediated lipogenic gene expression.
    Wang F; Liu JC; Zhou RJ; Zhao X; Liu M; Ye H; Xie ML
    Chem Biol Interact; 2017 Sep; 275():171-177. PubMed ID: 28803762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of AhR-NQO1 Signaling Pathway Protects Against Alcohol-Induced Liver Injury by Improving Redox Balance.
    Dong H; Hao L; Zhang W; Zhong W; Guo W; Yue R; Sun X; Zhou Z
    Cell Mol Gastroenterol Hepatol; 2021; 12(3):793-811. PubMed ID: 34082111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NIK links inflammation to hepatic steatosis by suppressing PPARα in alcoholic liver disease.
    Li Y; Chen M; Zhou Y; Tang C; Zhang W; Zhong Y; Chen Y; Zhou H; Sheng L
    Theranostics; 2020; 10(8):3579-3593. PubMed ID: 32206109
    [No Abstract]   [Full Text] [Related]  

  • 8. Peroxisome proliferator-activated receptor alpha (PPARalpha) agonist treatment reverses PPARalpha dysfunction and abnormalities in hepatic lipid metabolism in ethanol-fed mice.
    Fischer M; You M; Matsumoto M; Crabb DW
    J Biol Chem; 2003 Jul; 278(30):27997-8004. PubMed ID: 12791698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alcoholic fatty liver is enhanced in CYP2A5 knockout mice: The role of the PPARα-FGF21 axis.
    Chen X; Ward SC; Cederbaum AI; Xiong H; Lu Y
    Toxicology; 2017 Mar; 379():12-21. PubMed ID: 28131861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of mouse hepatic alpha-amino-beta-carboxymuconate-epsilon-semialdehyde decarboxylase, a key enzyme in the tryptophan-nicotinamide adenine dinucleotide pathway, by hepatocyte nuclear factor 4alpha and peroxisome proliferator-activated receptor alpha.
    Shin M; Kim I; Inoue Y; Kimura S; Gonzalez FJ
    Mol Pharmacol; 2006 Oct; 70(4):1281-90. PubMed ID: 16807375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms of alcoholic fatty liver: role of peroxisome proliferator-activated receptor alpha.
    Crabb DW; Galli A; Fischer M; You M
    Alcohol; 2004 Aug; 34(1):35-8. PubMed ID: 15670663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptor alpha protects against alcohol-induced liver damage.
    Nakajima T; Kamijo Y; Tanaka N; Sugiyama E; Tanaka E; Kiyosawa K; Fukushima Y; Peters JM; Gonzalez FJ; Aoyama T
    Hepatology; 2004 Oct; 40(4):972-80. PubMed ID: 15382117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic hypoxia-inducible factors inhibit PPARα expression to exacerbate acetaminophen induced oxidative stress and hepatotoxicity.
    Li D; Du Y; Yuan X; Han X; Dong Z; Chen X; Wu H; Zhang J; Xu L; Han C; Zhang M; Xia Q
    Free Radic Biol Med; 2017 Sep; 110():102-116. PubMed ID: 28583670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptomic signatures of peroxisome proliferator-activated receptor α (PPARα) in different mouse liver models identify novel aspects of its biology.
    Szalowska E; Tesfay HA; van Hijum SA; Kersten S
    BMC Genomics; 2014 Dec; 15(1):1106. PubMed ID: 25511156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fasting promotes the expression of SIRT1, an NAD+ -dependent protein deacetylase, via activation of PPARalpha in mice.
    Hayashida S; Arimoto A; Kuramoto Y; Kozako T; Honda S; Shimeno H; Soeda S
    Mol Cell Biochem; 2010 Jun; 339(1-2):285-92. PubMed ID: 20148352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of peroxisome proliferator activated receptor alpha ameliorates ethanol induced steatohepatitis in mice.
    Kong L; Ren W; Li W; Zhao S; Mi H; Wang R; Zhang Y; Wu W; Nan Y; Yu J
    Lipids Health Dis; 2011 Dec; 10():246. PubMed ID: 22208561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptor α activation induces hepatic steatosis, suggesting an adverse effect.
    Yan F; Wang Q; Xu C; Cao M; Zhou X; Wang T; Yu C; Jing F; Chen W; Gao L; Zhao J
    PLoS One; 2014; 9(6):e99245. PubMed ID: 24926685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elafibranor interrupts adipose dysfunction-mediated gut and liver injury in mice with alcoholic steatohepatitis.
    Li TH; Yang YY; Huang CC; Liu CW; Tsai HC; Lin MW; Tsai CY; Huang SF; Wang YW; Lee TY; Huang YH; Hou MC; Lin HC
    Clin Sci (Lond); 2019 Feb; 133(3):531-544. PubMed ID: 30602573
    [No Abstract]   [Full Text] [Related]  

  • 19. Disruption of peroxisome proliferator-activated receptor α in hepatocytes protects against acetaminophen-induced liver injury by activating the IL-6/STAT3 pathway.
    Zhang Z; Yao T; Zhao N; Liu H; Cheng H; Gonzalez FJ; Wang H; Wang G; Qu A; Wang Y
    Int J Biol Sci; 2022; 18(6):2317-2328. PubMed ID: 35414769
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatic Krüppel-like factor 16 (KLF16) targets PPARα to improve steatohepatitis and insulin resistance.
    Sun N; Shen C; Zhang L; Wu X; Yu Y; Yang X; Yang C; Zhong C; Gao Z; Miao W; Yang Z; Gao W; Hu L; Williams K; Liu C; Chang Y; Gao Y
    Gut; 2021 Nov; 70(11):2183-2195. PubMed ID: 33257471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.